Grifols (GRFS) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Grifols (GRFS) quarterly earnings & revenue
Grifols (GRFS) reported revenue of $2.01B for Q1 2026, down 3.2% year-over-year, with net income of $86.37M and diluted EPS of $0.13.
Over the last four reported quarters, Grifols generated $8.67B in revenue and $483.73M in net income.
Grifols's next earnings report is scheduled for July 28, 2026 before market open; analysts estimate EPS of $0.28.
Grifols quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $2.01B | -3.2% | $86.37M | $0.13 |
| Q4 2025 | $2.29B | -0.6% | $113.29M | $0.16 |
| Q3 2025 | $2.17B | +4.0% | $147.79M | $0.22 |
| Q2 2025 | $2.20B | +4.0% | $136.27M | $0.20 |
| Q1 2025 | $2.08B | +9.8% | $69.52M | $0.10 |
| Q4 2024 | $2.30B | +11.7% | $80.28M | $0.12 |
| Q3 2024 | $2.09B | +12.2% | $60.17M | $0.09 |
| Q2 2024 | $2.12B | +9.3% | $17.28M | $0.02 |
Grifols (GRFS) — frequently asked questions
When does Grifols (GRFS) report earnings next?
Grifols is expected to report earnings on July 28, 2026 before market open. Analysts estimate EPS of $0.28.
What was GRFS's revenue last quarter?
Grifols reported revenue of $2.01B in Q1 2026, down 3.2% from the same quarter a year earlier.
What was GRFS's EPS last quarter?
Grifols reported diluted EPS of $0.13 in Q1 2026.
Is Grifols profitable?
Grifols is currently profitable, with $483.73M in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)